May 26, 2023Axol Team Leader presents at global ALS conferenceAxol Team Leader presents at global ALS conference Stuart Prime, Research Team Leader at Axol, recently spoke at the 2nd…Author:
May 4, 2023How our license with The Francis Crick Institute could de-risk drug developmentHow our license with The Francis Crick Institute could de-risk…
April 25, 2023axoCellsTM Cortical Inhibitory InterneuronsCortical Inhibitory InterneuronsInterneurons are involved in major neurological disease types.…
April 12, 2023iPSC tech help clinic: cardiomyocytesAsk a cardiomyocyte expert your cardiomyocyte questions! On the 26th…
March 22, 2023Celebrating World Organoid Research Day 2023Celebrating World Organoid Research Day 2023Today we’re celebrating (and enjoying)…
March 8, 2023“I have a simple request for you all: HURRY UP!.” Stephen BrannanStephen BrannanLay Member of Court, Edinburgh Napier University, and Person…
February 13, 2023iPSC Tech Help Clinic: Microglial CellsAsk a scientist, Microglia Tech Clinic! On 1st March, Jessica…
February 8, 2023MPS disease models review: current status, opportunities and limitationsMPS disease models review: current status, opportunities and limitations A…Author: Jan Turner
August 26, 2022Transform in vitro assays with human iPSC-derived sensory neurons, mature in 21 daysWhy are Axol’s human iPSC-derived sensory neurons transforming in vitro…
December 1, 2022NECTAR 2022 in three minutesNectar 2022 The 32nd annual meeting of NECTAR (Network for…
November 3, 2022Sensory Neurons That Behave Like Sensory NeuronsWhen you work with sensory neurons in vitro, you want…
December 15, 2022Alzheimer’s Disease, genetic risk factors, and 3D modelsThree recently published studies of Alzheimer’s Disease (AD) research suggest…